NDC 16729-303 – Diltiazem Hydrochloride
Diltiazem Hydrochloride 120 mg/1 · Capsule, Extended Release · Oral
Product NDC16729-303
Product details
- Brand name
- Diltiazem Hydrochloride
- Generic name
- Diltiazem Hydrochloride
- Labeler
- Accord Healthcare, Inc.
- Dosage form
- Capsule, Extended Release
- Route
- Oral
- Marketing category
- ANDA · ANDA206997
- Marketed since
- September 11, 2020
- Listing expires
- December 31, 2026
- Pharmacologic class
- Calcium Channel Blocker
Active ingredients
- Diltiazem Hydrochloride 120 mg/1
Uses, dosage, side effects and warnings for Diltiazem Hydrochloride →
Package NDC codes (2)
| Package NDC | Description | Since |
|---|---|---|
| 16729-303-01 | 100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (16729-303-01) | Sep 11, 2020 |
| 16729-303-16 | 500 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (16729-303-16) | Sep 11, 2020 |
Other Diltiazem Hydrochloride products
- 50090-0451 Diltiazem Hydrochloride 60 mg/1 · Tablet, Film Coated · A-S Medication Solutions
- 50090-7401 Diltiazem Hydrochloride 60 mg/1 · Tablet · A-S Medication Solutions
- 50090-5416 Diltiazem Hydrochloride 120 mg/1 · Capsule, Extended Release · A-S Medication Solutions
- 50090-5466 Diltiazem Hydrochloride 180 mg/1 · Capsule, Extended Release · A-S Medication Solutions
- 50090-5452 Diltiazem Hydrochloride 240 mg/1 · Capsule, Extended Release · A-S Medication Solutions
- 50090-7815 Diltiazem Hcl 240 mg/1 · Capsule, Extended Release · A-S Medication Solutions
- 50090-6328 Diltiazem Hydrochloride 120 mg/1 · Capsule, Extended Release · A-S Medication Solutions
- 16729-304 Diltiazem Hydrochloride 180 mg/1 · Capsule, Extended Release · Accord Healthcare, Inc.
- 16729-305 Diltiazem Hydrochloride 240 mg/1 · Capsule, Extended Release · Accord Healthcare, Inc.
- 0228-2918 Diltiazem Hydrochloride 360 mg/1 · Capsule, Extended Release · Actavis Pharma, Inc.
- 62332-725 Diltiazem Hydrochloride 120 mg/1 · Capsule, Extended Release · Alembic Pharmaceuticals Inc.
- 62332-726 Diltiazem Hydrochloride 180 mg/1 · Capsule, Extended Release · Alembic Pharmaceuticals Inc.